The World Health Organization’s (WHO’s) Representative for Ghana, Dr. Owen Laws Kaluwa, has called on African regulators in the health sector to apply WHO guidelines to improve the regulatory regime of medical products.
According to him, governments must come together with stakeholders, to beef up sensitisation when it comes to ethical and regulatory approval of clinical trials of new medicines.
According effective mechanisms ought to be adopted to encourage in-depth research, to find solutions to tropical diseases.
Dr. Owen Kaluwa was speaking in an interview with Newsghana.com.gh at the 3rd Biennial Conference on Medical Products Regulation in Africa dubbed “Sustaining the Momentum for Regulatory Harmonization in Africa,” organized by Penplusbytes (www.penplusbytes.org) in collaboration with the West African Health Organisation (WAHO) and with support from the Government of Ghana at Alisa Hotel, from 27 and 28 November 2017.
On the accessions of the WHO’s standard of work, he said it is more important than ever and even conducted under strengthened rules for selection of experts and for declarations of interests.
He said, there is an Expert Committee system which is the backbone of WHO’s normative function. “The technical guidance is provided online and is widely used. The website, with the 75 medicines quality assurance-related guidelines adopted through the Committee and the online version of The International Pharmacopoeia, is at the top of the Organization’s list for web queries,” he noted.
He therefore, urged governments and all stakeholders to work together to improve the effectiveness of regulatory systems worldwide, thus ensuring continuous availability of safe and effective drug products.